To study effect of Shefalika Patra Kwath and Agnikarma in the Management of Gridhrasi.

A Randomized Controlled Trial Of Effect of Shefalika Patra Kwath with Agnikarma Compared to Panchmooli Kwath with Agnikarma in Gridhrasi With Special Reference to Sciatica - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080758

Enrollment

102

Registered

2025-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G570- Lesion of sciatic nerve

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged between 20to60 years irrespective of caste religion socioeconomic and educational status will be included. Patients present with classical signs and symptoms of Gridhrasi. Patients with straight leg raising (SLR) test positive between 30 degree and 70 degree. Patient willing and able to participate in the study.Patient who had not participated in any research work since last six months will be included.

Exclusion criteria

Exclusion criteria: Patient with age group less than 20 years and more than 60 years will be excluded from the study. History of any fracture of vertebral joint 0r surgical or diagnostic intervention with reference to affected joints will be excluded. Gross disability in performing daily normal routine that is bedridden patient or confined to a wheelchair will be excluded. Patient with co-morbidities such as gouty arthritis or rheumatoid arthritis or psoriatic arthritis and tubercular arthritis or Potts Spine and Cauda equina syndrome will be excluded.Patients of Gridhrasi with uncontrolled hypertension that is systolic BP more than 140mmHg and diastolic BP more than 100mmHg and uncontrolled diabetes mellitus that is Fasting sugar more than 130gm per dl and Post meal sugar more than 200gm per dl will be excluded Patients having any neuropathy will be excluded. Patient with evidence of malignancy. Pregnant or lactating women. Patients in which Agnikarma is contraindicated and those who are contraindicated for sudation will be excluded.

Design outcomes

Primary

Measure	Time frame
To Evaluate the efficacy of Shefalika Patra Kwath along with Agnikarma particularly on the Gradations of Parameters score in the management of Gridhrasi w.s.r. to Sciatica in duration of 30 days. To Evaluate the efficacy of Panchmooli Kwath with Agnikarma particularly on the Gradations of Parameters score in the management of Gridhrasi w.s.r. to Sciatica in duration of 30 days. To compare the effect of Shefalika Patra Kwath with Agnikarma and Panchmooli Kwath with Agnikarma in the management of Gridhrasi w.s.r. to Sciatica, particularly on the Gradations of Parameters. To assess the effect on the VAS Scale & WOMAC Scale in Gridhrasi(Sciatica).Timepoint: 0th Day, 15th Day, 30th Day	—

Measure

Time frame

To Evaluate the efficacy of Shefalika Patra Kwath along with Agnikarma particularly on the Gradations of Parameters score in the management of Gridhrasi w.s.r. to Sciatica in duration of 30 days. To Evaluate the efficacy of Panchmooli Kwath with Agnikarma particularly on the Gradations of Parameters score in the management of Gridhrasi w.s.r. to Sciatica in duration of 30 days. To compare the effect of Shefalika Patra Kwath with Agnikarma and Panchmooli Kwath with Agnikarma in the management of Gridhrasi w.s.r. to Sciatica, particularly on the Gradations of Parameters. To assess the effect on the VAS Scale & WOMAC Scale in Gridhrasi(Sciatica).Timepoint: 0th Day, 15th Day, 30th Day

—

Secondary

Measure	Time frame
To review and study the literature of Gridhrasi. To review and study the literature of Sciatica.Timepoint: 0th Day, 15th Day, 30th Day	—

Countries

India

Contacts

Public ContactJayant Gulhane

Government Ayurveda College And Hospital Nagpur

jayant.gulhane.62.6@gmail.com9822922399

Outcome results